🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/12/2024 | 98,50 | 99,53 | 98,43 | 99,48 | +1,13% | 1,12% | 6.598.200 |
| 30/12/2024 | 99,57 | 99,57 | 98,27 | 98,37 | -1,33% | 1,31% | 6.848.700 |
| 27/12/2024 | 99,50 | 100,35 | 99,24 | 99,70 | -0,17% | 1,12% | 6.173.600 |
| 26/12/2024 | 99,09 | 99,94 | 98,92 | 99,87 | +0,42% | 1,03% | 4.760.300 |
| 24/12/2024 | 99,22 | 99,64 | 98,80 | 99,45 | +0,08% | 0,85% | 3.713.500 |
| 23/12/2024 | 99,09 | 99,59 | 98,20 | 99,37 | +1,35% | 1,40% | 8.460.500 |
| 20/12/2024 | 98,83 | 99,68 | 97,90 | 98,05 | -1,48% | 1,80% | 29.289.700 |
| 19/12/2024 | 98,56 | 99,94 | 97,82 | 99,52 | +1,20% | 2,15% | 12.110.800 |
| 18/12/2024 | 100,19 | 101,50 | 98,27 | 98,34 | -1,72% | 3,22% | 11.993.400 |
| 17/12/2024 | 99,90 | 100,80 | 99,36 | 100,06 | +0,00% | 1,44% | 13.975.100 |
| 16/12/2024 | 101,25 | 102,28 | 100,05 | 100,06 | -1,90% | 2,20% | 11.701.100 |
| 13/12/2024 | 101,13 | 102,57 | 100,53 | 102,00 | +0,74% | 2,02% | 10.118.200 |
| 12/12/2024 | 101,69 | 103,00 | 100,12 | 101,25 | +1,50% | 2,83% | 9.554.400 |
| 11/12/2024 | 100,70 | 101,45 | 99,26 | 99,75 | -1,24% | 2,17% | 21.613.000 |
| 10/12/2024 | 103,77 | 103,77 | 100,74 | 101,00 | -2,69% | 2,92% | 11.359.400 |
| 09/12/2024 | 102,86 | 105,07 | 102,33 | 103,79 | +0,68% | 2,66% | 19.162.500 |
| 06/12/2024 | 103,61 | 103,95 | 102,69 | 103,09 | -0,44% | 1,22% | 11.470.700 |
| 05/12/2024 | 101,49 | 104,14 | 101,35 | 103,55 | +2,15% | 2,75% | 11.062.700 |
| 04/12/2024 | 102,03 | 102,09 | 101,05 | 101,37 | -0,47% | 1,02% | 11.315.000 |
| 03/12/2024 | 100,75 | 102,45 | 100,62 | 101,85 | +1,23% | 1,82% | 11.395.600 |
| 02/12/2024 | 101,73 | 101,85 | 100,46 | 100,61 | -1,01% | 1,37% | 13.703.100 |
| 29/11/2024 | 102,88 | 103,04 | 101,53 | 101,64 | -1,44% | 1,47% | 6.081.200 |
| 27/11/2024 | 101,65 | 103,45 | 101,64 | 103,12 | +1,48% | 1,78% | 9.802.200 |
| 26/11/2024 | 101,48 | 101,80 | 99,70 | 101,62 | +0,45% | 2,07% | 9.324.100 |
| 25/11/2024 | 100,09 | 101,74 | 99,51 | 101,16 | +2,00% | 2,23% | 34.659.100 |
| 22/11/2024 | 100,33 | 101,79 | 98,93 | 99,18 | -0,68% | 2,85% | 14.031.200 |
| 21/11/2024 | 97,72 | 100,48 | 96,95 | 99,86 | +2,48% | 3,61% | 15.670.300 |
| 20/11/2024 | 96,98 | 98,84 | 96,66 | 97,44 | +0,93% | 2,25% | 12.136.800 |
| 19/11/2024 | 96,73 | 97,55 | 95,26 | 96,54 | -0,02% | 2,37% | 13.093.100 |
| 18/11/2024 | 96,56 | 97,29 | 95,42 | 96,56 | +0,26% | 1,94% | 14.139.900 |